b12 injection sites subcutaneous Optimal for Maximum Absorption and Benefits Choosing the Right Needle and

No obvious systemic adverse reactions were observed in tested animals even at a relatively high daily dose up to 60 mg/kg/d, confirming its promising safety profile and therapeutic efficacy for prospective ovarian cancer treatment

The Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) tool was used to assess the certainty of the evidence for the two primary biochemical outcomesserum vitamin B12 concentration increase and homocysteine reductionacross all included studies, and separately for randomised controlled trials (RCTs) and observational studies

Dosage and method of use of in cats and dogs: 0.25-0.3 ml

(PubMed) Stevens VL, McCullough ML, Sun J, Gapstur SM

60% ,